$GMAB Key takeaways $JNJ 
1Q20 Darzalex sales of $937m, up 13% from $830m in 4Q19, and c4% ahead of consensus
1Q sales is progressing towards guidance of $3.9-4.2bn, pending COVID impact updates
Buy for next wave of pipeline, now mostly free, CD3/20 partnering most important